Vontobel Holding’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Vontobel Holding’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-7,500	Closed	-$543K	–	1154
2023 Q3	$543K	Hold	7,500	–	–	0.01%	743
2023 Q2	$567K	Hold	7,500	–	–	0.01%	759
2023 Q1	$570K	Hold	7,500	–	–	0.01%	746
2022 Q4	$589K	Hold	7,500	–	–	0.01%	712
2022 Q3	$535K	Hold	7,500	–	–	0.01%	695
2022 Q2	$562K	Hold	7,500	–	–	0.01%	687
2022 Q1	$597K	Buy	7,500 +1,250	+20%	+$96.9K	0.01%	741
2021 Q4	$507K	Buy	6,250 +1,250	+25%	+$98.8K	﹤0.01%	805
2021 Q3	$387K	Hold	5,000	–	–	﹤0.01%	869
2021 Q2	$402K	Buy	+5,000	New	+$397K	﹤0.01%	825

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

JGCM

Joseph Group Capital Management Columbus, Ohio $476M AUM 21.21% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Vontobel Holding's PJP Position: Q4 2023 in Review

Vontobel Holding sold out of Invesco Pharmaceuticals ETF (PJP) in Q4 2023, closing a stake of 7,500 shares — an estimated $543K sold.

Vontobel Holding first reported a position in PJP in Q2 2021 and held it in 10 quarters. The position peaked at $597K in Q1 2022. 86 funds tracked by Wall St. Rank hold PJP as of Q4 2023.

Vontobel Holding reported no remaining Invesco Pharmaceuticals ETF position as of Q4 2023 after selling out during the quarter.
Vontobel Holding sold 7,500 Invesco Pharmaceuticals ETF shares in Q4 2023, an estimated $543K.
Vontobel Holding first reported a position in Invesco Pharmaceuticals ETF in Q2 2021 and held it in 10 quarters.
Vontobel Holding's Invesco Pharmaceuticals ETF position peaked at $597K in Q1 2022.
86 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q4 2023.

Based on Vontobel Holding's 13F filing for Q4 2023, filed 30 Jan 2024.